# IDBiologics, Inc. — Form D

IDBiologics, Inc. of NASHVILLE, TN, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-20. The offering totals $3.5M, of which $3.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2020-05-20
- Form: D
- Accession: 0001812623-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.5M
- Amount sold: $3.1M
- Remaining: $400K
- Minimum investment: $1
- Investors: 13
- Date of first sale: 2020-05-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-367393

## Issuer

- Name: IDBiologics, Inc.
- CIK: 0001812623
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 2101 20TH AVE SOUTH, NASHVILLE, TN, 37212
- Phone: (408) 899-9356

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Charles F Haines | Director | Nashville, TN |
| Charles F Haines | Executive Officer | Nashville, TN |
| Kenneth J Kelley | Director | Nashville, TN |
| James E Crowe, Jr. | Director | Nashville, TN |
| Mike E LaBarre | Director | Nashville, TN |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-03-03](https://search.stillhousedata.com/formd/0001812623-21-000001) | D/A | $4.3M | $4.3M |

## More

- [CIK 1812623 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1812623&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001812623-20-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.